The Mutational Landscape of Early-Onset Breast Cancer: A Next-Generation Sequencing Analysis
Authors:
Open Access
- 21 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11, 797505
Abstract
Background: Around 5%–7% of breast cancer cases are diagnosed in women younger than 40, making it the leading cause of female cancer in the 25- to 39-year-old age group. Unfortunately, young age at diagnosis is linked to a more aggressive tumor biology and a worse clinical outcome. The identification of the mutational landscape of breast cancer in this age group could optimize the management.Methods: We performed NGS analysis in paraffin blocks and blood samples of 32 young patients with breast cancer [via NGS in patients with early-onset breast cancer compared to their older counterparts. Although the sample size is small and no statistically significant differences were detected, we highlight the need of genetic testing to most patients in this subgroup.Keywords
This publication has 25 references indexed in Scilit:
- Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast CancerJournal of Clinical Oncology, 2013
- APC Polymorphisms and the Risk of Colorectal Neoplasia: A HuGE Review and Meta-AnalysisAmerican Journal of Epidemiology, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The landscape of cancer genes and mutational processes in breast cancerNature, 2012
- Breast cancer in young womenBreast Cancer Research, 2010
- Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage DiseaseJournal of the American College of Surgeons, 2009
- ATM and breast cancer susceptibilityOncogene, 2006
- ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility allelesNature Genetics, 2006
- Factors influencing the effect of age on prognosis in breast cancer: population based study Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancerBMJ, 2000
- Heterozygous ATM mutations do not contribute to early onset of breast cancerNature Genetics, 1997